Body Composition Analyzers Market worth $1.2 billion by 2029

The body composition analyzers market, estimated at USD 0.8 billion in 2024 and projected to achieve USD 1.2 billion by 2029 with a CAGR of 9.3%, is primarily driven by increasing health consciousness, escalating obesity prevalence, and advancements in technology. Key players such as Omron Corporation, Hologic Inc., and GE Healthcare play significant roles in this market. In 2023, GE Healthcare led the market with its cutting-edge medical imaging and diagnostic devices, leveraging its global distribution channel. Omron Corporation closely followed, renowned for its innovative and user-friendly health monitoring devices and strong commitment to research and development. Hologic Inc. secured the third-largest market share, specializing in advanced diagnostic solutions, particularly notable for its precision in bone density and body composition analysis.
read more..